The Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Alzheimers Disease & Other Dementias

• Publication date

  2014-01-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/1533317513518651PMID 24408754PMCID PMC10852600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MCP-1/CCR2 signaling-mediated astrocytosis is accelerated in a transgenic mouse model of SOD1-mutated familial ALS

  2013cited by this paper
• Histone Deacetylases Enzyme, Copper, and IL-8 Levels in Patients With Alzheimer’s Disease

  2013cited by this paper
• Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease

  2013cited by this paper
• Enhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's Disease

  2013cited by this paper
• Fluid biomarkers in Alzheimer’s disease – current concepts

  2013influential reference
• The multifactorial nature of Alzheimer's disease for developing potential therapeutics.

  2013cited by this paper
• CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease.

  2013cited by this paper
• Systemic immune system alterations in early stages of Alzheimer's disease.

  2013cited by this paper
• Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.

  2012cited by this paper
• A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines

  2012cited by this paper
• T Cell Recruitment in the Brain during Normal Aging

  2012cited by this paper
• Soluble CCL5 Derived from Bone Marrow‐Derived Mesenchymal Stem Cells and Activated by Amyloid β Ameliorates Alzheimer's Disease in Mice by Recruiting Bone Marrow‐Induced Microglia Immune Responses

  2012cited by this paper
• Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer’s disease

  2012cited by this paper
• CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease

  2012cited by this paper
• Inflammation, Endoplasmic Reticulum Stress, Autophagy, and the Monocyte Chemoattractant Protein-1/CCR2 Pathway

  2012cited by this paper
• Elevated Plasma MCP-1 Concentration Following Traumatic Brain Injury as a Potential “Predisposition” Factor Associated with an Increased Risk for Subsequent Development of Alzheimer's Disease

  2012cited by this paper
• Hematopoietic CC-Chemokine Receptor 2 (CCR2) Competent Cells Are Protective for the Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer’s Disease

  2012cited by this paper
• Monocyte chemotactic protein-induced protein (MCPIP) promotes inflammatory angiogenesis via sequential induction of oxidative stress, endoplasmic reticulum stress and autophagy.

  2012cited by this paper
• MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.

  2011influential reference
• CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease

  2011influential reference
• The blood-brain barrier, chemokines and multiple sclerosis.

  2011cited by this paper
• Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples

  2011cited by this paper
• Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity.

  2011influential reference
• CCL5 induces a pro-inflammatory profile in microglia in vitro.

  2011cited by this paper
• CC Chemokine Receptor 2 Deficiency Aggravates Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

  2011cited by this paper
• Inflammation and oxidative damage in Alzheimer's disease: friend or foe?

  2011cited by this paper
• MCP-1-induced protein attenuates endotoxin-induced myocardial dysfunction by suppressing cardiac NF-кB activation via inhibition of IкB kinase activation.

  2011cited by this paper
• The role of microglial cell subsets in Alzheimer's disease.

  2011cited by this paper
• CXCL8 protects human neurons from amyloid-β-induced neurotoxicity: relevance to Alzheimer's disease.

  2011cited by this paper
• Chemokines in CSF of Alzheimer's disease patients.

  2011influential reference
• Visinin‐like protein‐1: Diagnostic and prognostic biomarker in Alzheimer disease

  2011cited by this paper
• CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity

  2011influential reference
• [Changes of nuclear factor and inflammatory chemotactic factors in brain of patients with Alzheimer's disease].

  2011cited by this paper
• Growth factors and cytokines/chemokines as surrogate biomarkers in cerebrospinal fluid and blood for diagnosing Alzheimer's disease and mild cognitive impairment.

  2010cited by this paper
• Involvement of phosphoinositide 3-kinase gamma in the neuro-inflammatory response and cognitive impairments induced by beta-amyloid 1-40 peptide in mice.

  2010cited by this paper
• RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.

  2010cited by this paper
• CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

  2010cited by this paper
• Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis

  2010cited by this paper
• P1‐317: Role of GAP‐43 in axonal damage and regeneration in neuroinflammatory situations

  2010cited by this paper
• Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease.

  2010cited by this paper
• The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease

  2010influential reference
• Neuroinflammatory processes in Alzheimer’s disease

  2010cited by this paper
• Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-alpha-dependent.

  2010cited by this paper
• Morphine induces the release of CCL5 from astrocytes: Potential neuroprotective mechanism against the HIV protein gp120

  2010cited by this paper
• Chemoattractants and receptors in Alzheimer's disease.

  2010cited by this paper
• Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.

  2010cited by this paper
• The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases.

  2010cited by this paper
• Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5

  2010cited by this paper
• CCR5 deficiency induces astrocyte activation, Abeta deposit and impaired memory function.

  2009cited by this paper
• Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide.

  2009influential reference
• Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.

  2009influential reference
• Monocyte Chemoattractant Protein‐1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease

  2009influential reference
• Association between altered systemic inflammatory interleukin‐1β and natural killer cell activity and subsequently agitation in patients with alzheimer disease

  2009cited by this paper
• Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis

  2009cited by this paper
• Chemokines and neuromodulation.

  2008cited by this paper
• Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimer's disease in the Chinese population.

  2008cited by this paper
• Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.

  2008cited by this paper
• Plasma levels of the beta chemokine regulated upon activation, normal T cell expressed, and secreted (RANTES) correlate with severe brain injury.

  2008cited by this paper
• Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease

  2008cited by this paper
• Chemokines and their receptors: drug targets in immunity and inflammation.

  2008cited by this paper
• Decreased Fractalkine and Increased IP-10 Expression in Aged Brain of APPswe Transgenic Mice

  2008cited by this paper
• Decreased CXCL12 (SDF-1) Plasma Levels in Early Alzheimer's Disease: A Contribution to a Deficient Hematopoietic Brain Support?

  2008cited by this paper
• Systemic immune aberrations in Alzheimer's disease patients.

  2008cited by this paper
• Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.

  2008cited by this paper
• Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina.

  2008cited by this paper
• Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease

  2008influential reference
• Decreased Plasma and Cerebrospinal Fluid Levels of Stem Cell Factor in Patients with Early Alzheimer's Disease

  2008cited by this paper
• YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor.

  2008cited by this paper
• IL-8 Induces Expression of Matrix Metalloproteinases, Cell Cycle and Pro-Apoptotic Proteins, and Cell Death in Cultured Neurons

  2007cited by this paper
• Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease.

  2007cited by this paper
• Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

  2007cited by this paper
• Modulation of interleukin-1β mediated inflammatory response in human astrocytes by flavonoids: Implications in neuroprotection

  2007cited by this paper
• Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce?

  2007cited by this paper
• Differential Expression of CXCL12 and CXCR4 During Human Fetal Neural Progenitor Cell Differentiation

  2007cited by this paper
• Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease.

  2007cited by this paper
• The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies.

  2007cited by this paper
• Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein‐1 in cultured human brain‐derived progenitor cells

  2006cited by this paper
• Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

  2006influential reference
• The many roles of chemokines and chemokine receptors in inflammation.

  2006cited by this paper
• The mouse CCR2 gene is regulated by two promoters that are responsive to plasma cholesterol and peroxisome proliferator-activated receptor gamma ligands.

  2005influential reference
• Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.

  2005cited by this paper
• Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease.

  2005cited by this paper
• The interleukin‐1 signalling pathway in astrocytes: a key contributor to inflammation in the brain

  2005cited by this paper
• Measurement of Thirteen Biological Markers in CSF of Patients with Alzheimer’s Disease and Other Dementias

  2005cited by this paper
• Macrophage Inflammatory Protein 2 Inhibits β-Amyloid Peptide (1-42)-Mediated Hippocampal Neuronal Apoptosis through Activation of Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Signaling Pathways

  2005cited by this paper
• Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways.

  2005cited by this paper
• Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation

  2005cited by this paper
• Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell‐microglia interaction

  2005cited by this paper
• ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis*

  2005cited by this paper
• The role of mast cells and fibre type in ischaemia reperfusion injury of murine skeletal muscles

  2004cited by this paper
• Upregulation of RANTES Gene Expression in Neuroglia by Japanese Encephalitis Virus Infection

  2004cited by this paper
• Chemokines: role in inflammation and immune surveillance

  2004cited by this paper
• The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age‐related macular degeneration

  2004cited by this paper
• SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study.

  2003cited by this paper
• Regulation of chemokine receptor expression in human microglia and astrocytes.

  2003cited by this paper
• Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system.

  2003cited by this paper
• Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients

  2003cited by this paper
• SDF‐1α Is Expressed in Astrocytes and Neurons in the AIDS Dementia Complex: An In Vivo and In Vitro Study

  2003cited by this paper
• Role of the α‐chemokine stromal cell‐derived factor (SDF‐1) in the developing and mature central nervous system

  2003cited by this paper
• Structure, function, and inhibition of chemokines.

  2002cited by this paper

• Inflammatory Mediators of Alzheimer's Disease Characterized in a Mouse Model (APP/PS1).

  2026cites this paper
• Neuroinflammation as a Central Mechanism in Alzheimer’s Disease: Therapeutic Insights from Schiff Base Derivatives

  2026cites this paper
• Chemokines and their receptors: The importance of their expression for an appropriate regulation of the immune response in health and disease.

  2026cites this paper
• The Interplay of Inflammation and Gut-Microbiota Dysbiosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential

  2025cites this paper
• Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms

  2025cites this paper
• Combined Ionizing Radiation Caused Cognition and Non-Cognition Behavior Benefits and Modulated Microglial Activity in Wild-Type and Alzheimer’s-like Transgenic Mice

  2025cites this paper
• An Alzheimer’s disease-associated common regulatory variant in a PTK2B intron alters microglial function

  2025cites this paper
• Combined Ionizing Radiation Exposure Improves Behavioral Symptoms and Modulates Brain Innate Immune System Activity in the Tau P301S Mice Line

  2025cites this paper
• Targeting the chemokine-microglia nexus: A novel strategy for modulating neuroinflammation in Alzheimer's disease

  2025cites this paper
• Association between serum chemokines levels and delayed neurocognitive recovery after non-cardiac surgery in elderly patients: a nested case–control study

  2025cites this paper
• Unraveling the cGAS-STING pathway in Alzheimer's disease: A new Frontier in neuroinflammation and therapeutic strategies.

  2025cites this paper
• The GLP-1 Agonist Semaglutide Ameliorates Cognitive Regression in P301S Tauopathy Mice Model via Autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization.

  2025cites this paper
• Highlighting the Effect of Pro-inflammatory Mediators in the Pathogenesis of Periodontal Diseases and Alzheimer’s Disease

  2024cites this paper
• Chemokines in neurodegenerative diseases

  2024cites this paper
• Modulating the blood-brain barrier in CNS disorders: A review of the therapeutic implications of secreted protein acidic and rich in cysteine (SPARC).

  2024cites this paper
• Role of chemokines in aging and age-related diseases.

  2024cites this paper
• Microglia regulate motor neuron plasticity via reciprocal fractalkine and adenosine signaling

  2024cites this paper
• Homocysteine decreases VEGF, EGF, and TrkB levels and increases CCL5/RANTES in the hippocampus: Neuroprotective effects of rivastigmine and ibuprofen.

  2024cites this paper
• Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease

  2024cites this paper
• Microglia regulate motor neuron plasticity via reciprocal fractalkine/adenosine signaling

  2024cites this paper
• Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease

  2024cites this paper
• Molecular mechanisms and genetics of Alzheimer’s disease

  2023cites this paper
• Comparison of Neuroinflammation Induced by Hyperphosphorylated Tau Protein Versus Ab42 in Alzheimer’s Disease

  2023cites this paper
• Investigation of MIF gene promoter variations and their haplotypes in the Alzheimer disease in Turkish population

  2023cites this paper
• The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease

  2023cites this paper
• EEF1A1 is Involved the Regulating Neuroinflammatory Processes in Parkinson's Disease.

  2023cites this paper
• Collaborative plasma biomarkers for Parkinson disease development and progression: A cross‐sectional and longitudinal study

  2023cites this paper
• Amyloids and brain cancer: molecular linkages and crossovers

  2023cites this paper
• Chemokines in patients with Alzheimer's disease: A meta-analysis

  2023cites this paper
• B Lymphocytes in Alzheimer’s Disease—A Comprehensive Review

  2022cites this paper
• Evaluation of the inhibition of Neuroinflammation by Quassin

  2022cites this paper
• Implications of fractalkine on glial function, ablation and glial proteins/receptors/markers—understanding its therapeutic usefulness in neurological settings: a narrative review

  2022cites this paper
• The relationship between chronic immune response and neurodegenerative damage in long COVID-19

  2022cites this paper
• Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer’s disease

  2022cites this paper
• Lead-exposure associated miRNAs in humans and Alzheimer’s disease as potential biomarkers of the disease and disease processes

  2022cites this paper
• Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer's disease patients.

  2022cites this paper
• Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases

  2022cites this paper
• Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 Mice

  2021cites this paper
• Supplementation with ribonucleotide-based ingredient (Ribodiet®) lessens oxidative stress, brain inflammation, and amyloid pathology in a murine model of Alzheimer.

  2021cites this paper
• Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors.

  2021cites this paper
• Differential chemokine alteration in the variants of primary progressive aphasia—a role for neuroinflammation

  2021cites this paper
• Shared Genetic Etiology between Alzheimer’s Disease and Blood Levels of Specific Cytokines and Growth Factors

  2021cites this paper
• Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events

  2021cites this paper
• Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties.

  2021cites this paper
• Altered protein secretion in Batten disease

  2021cites this paper
• Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer’s Disease

  2021cites this paper
• Ameliorating Alzheimer’s-like Pathology by Minocycline via Inhibiting Cdk5/p25 Signaling

  2021cites this paper
• Diagnostic potential of urinary monocyte chemoattractant protein‐1 for Alzheimer’s disease and amnestic mild cognitive impairment

  2020cites this paper
• CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer’s Disease

  2020cites this paper
• DNA methylation of IL-4 gene and the association with childhood trauma in panic disorder.

  2020cites this paper
• Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways

  2020cites this paper
• Tanshinone IIA Alleviates CCL2-Induced Leaning memory and Cognition Impairment in Rats: A Potential Therapeutic Approach for HIV-Associated Neurocognitive Disorder

  2020cites this paper
• Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat model

  2020cites this paper
• The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system.

  2019cites this paper
• Neurovascular Dysfunction in Alzheimer Disease

  2019cites this paper
• Protective effect of ISO-1 against advanced glycation end product aggravation of PC12 cell injury induced by Aβ1–40

  2019cites this paper
• Gene expression pattern of CCL2, CCL3, and CXCL8 in patients with bipolar disorder

  2019cites this paper
• Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins

  2019cites this paper
• The Effects of D-aspartate on Neurosteroids, Neurosteroid Receptors, and Inflammatory Mediators in Experimental Autoimmune Encephalomyelitis.

  2019cites this paper
• Modulation of SPARC/Hevin Proteins in Alzheimer’s Disease Brain Injury

  2019cites this paper
• Neutralization of IL‐17 rescues amyloid‐β‐induced neuroinflammation and memory impairment

  2019cites this paper
• Systemic and CNS inflammation crosstalk: implications for Alzheimer's Disease.

  2019cites this paper
• University of Birmingham Neutralization of IL-17 rescues amyloid--induced neuroinflammation and memory impairment

  2019cites this paper
• Investigation of inflammatory and oxidative stress mechanisms in the disruption of white matter structure and function following chronic cerebral hypoperfusion

  2019cites this paper
• Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc03042e

  2019cites this paper
• Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology

  2019cites this paper
• Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer’s patients in a human blood brain barrier model

  2018cites this paper
• Can the peripheral innate immune system be involved in the onset of the development of Alzheimer ’ s disease ?

  2018cites this paper
• Astrocyte-specific overexpression of Nrf2 protects against optic tract damage and behavioural alterations in a mouse model of cerebral hypoperfusion

  2018cites this paper
• The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer’s disease

  2018cites this paper
• URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease

  2018cites this paper
• CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer’s disease

  2018cites this paper
• Chemokines as new inflammatory players in the pathogenesis of epilepsy.

  2017cites this paper
• Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer's disease

  2017cites this paper
• Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis.

  2017influential citation
• (Putative) sex differences in neuroimmune modulation of memory

  2017cites this paper
• Acute Hypoxia Induced an Imbalanced M1/M2 Activation of Microglia through NF-κB Signaling in Alzheimer’s Disease Mice and Wild-Type Littermates

  2017cites this paper
• T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers

  2017cites this paper
• Enhanced Ccl2-Ccr2 signaling drives more severe choroidal neovascularization with aging.

  2016cites this paper
• Increased levels of MIP‐1α in CSF and serum of ALS

  2016cites this paper
• Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer’s Disease

  2016cites this paper
• Early alterations in blood and brain RANTES and MCP-1 expression and the effect of exercise frequency in the 3xTg-AD mouse model of Alzheimer's disease.

  2016cites this paper
• Classical and Alternative Activation of Cyanobacterium Oscillatoria sp. Lipopolysaccharide-Treated Rat Microglia in vitro.

  2016cites this paper
• APOE genotype‐dependent modulation of astrocyte chemokine CCL3 production

  2015cites this paper
• The Effects of Chronic Intermittent Hypoxia on Oxidative Stress and Inflammation

  2015cites this paper
• The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.

  2015cites this paper
• Inflammation in Alzheimer’s Disease and Molecular Genetics: Recent Update

  2015cites this paper
• Neuronal Cellular Responses to Extremely Low Frequency Electromagnetic Field Exposure: Implications Regarding Oxidative Stress and Neurodegeneration

  2014cites this paper
• An Alzheimer’s disease-associated common regulatory variant in PTK2B has causal effects on microglial function

  year unknowncites this paper